20 February 2026

Dapagliflozin PBS update in CKD: Expert overview

1 minute read

Nephrologist Prof Eugenia Pedagogos reviews the new PBS listing for dapagliflozin in chronic kidney disease, discusses clinical data, and frames the clinical implications for CKD management.

In this Product Explainer:

Nephrologist Prof Eugenia Pedagogos reviews the new PBS listing for Forxiga® (dapagliflozin) in chronic kidney disease, discusses clinical data, and frames the clinical implications for CKD management (5 mins).

This video was produced with funding from AstraZeneca.

End of content

No more pages to load

Register for a new account

Email Address

Password

Confirm Password

First Name

Last Name

Full Name LEAVE THIS BLANK

What field do you work in?

Type of University work:

Industry Specialty:

Other:

Billing Address

First Name

Last Name

Address 1

Address 2

City

State

Postal Code

Country

Phone

Payment Information We Accept Visa, Mastercard, American Express, and Discover

Card Number

Expiration Date /

Security Code (CVC) (what's this?)

I agree to the Terms and conditions and privacy policy *

Processing...

Dapagliflozin PBS update in CKD: Expert overview